论文部分内容阅读
目的:分析多发性腔隙性脑梗死行低分子肝素钙与银杏达莫等联合治疗的效果。方法:回顾性分析2014年3月-2015年3月本院收治的多发性腔隙性脑梗死70例患者临床资料,按数字表法分为观察组和对照组,每组35例。对照组行阿司匹林肠溶片与低分子肝素钙治疗,观察组在其基础上行银杏达莫治疗,观察两组疗效。结果:治疗后,观察组总有效率94.29%显著比对照组54.29%高,且纤维蛋白原、全血粘度与红细胞压积情况均比对照组优,比较差异均有统计学意义(P<0.05)。结论:多发性腔隙性脑梗死患者行低分子肝素钙与银杏达莫等联合治疗的效果显著,可改善其临床症状与血液流变学指标,值得推广。
Objective: To analyze the effect of combined therapy of low molecular weight heparin and gingko-damo in multiple lacunar infarction. Methods: The clinical data of 70 patients with multiple lacunar infarction in our hospital from March 2014 to March 2015 were retrospectively analyzed. According to the digital table, the patients were divided into observation group and control group, 35 cases in each group. The control group received aspirin enteric-coated tablets and low-molecular-weight heparin calcium. The observation group was treated with ginkgo-dipyridamole on the basis of the above treatment. The curative effect of the two groups was observed. Results: After treatment, the total effective rate in the observation group was 94.29%, significantly higher than that in the control group (54.29%), and the fibrinogen, whole blood viscosity and hematocrit were all better than those in the control group, with statistical significance (P <0.05 ). Conclusion: The combination of low molecular weight heparin and ginkgo biloba and other drugs in patients with multiple lacunar infarction significantly improves the clinical symptoms and hemorheology, which is worthy of popularization.